We are live on ! Find out more
OASM

Oasmia Pharmaceutical AB
OASM

Delisted

OASM was delisted on the 21st of August, 2019.

4 hedge funds and large institutions have $49K invested in Oasmia Pharmaceutical AB in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

33% less funds holding

Funds holding: 64 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

78% less capital invested

Capital invested by funds: $226K → $49K (-$177K)

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$24K +$24.2K +18,439 New
Citadel Advisors
2
Citadel Advisors
Florida
$22K -$2.3K -1,754 -9%
UBS Group
3
UBS Group
Switzerland
$3K +$700 +534 +26%
SCM
4
Sio Capital Management
New York
-$179K -203,170 Closed
SM
5
Sabby Management
Florida
-$17K -19,000 Closed
Bank of New York Mellon
6
Bank of New York Mellon
New York
-$12K -13,450 Closed